{"id":"NCT04501666","sponsor":"Galderma R&D","briefTitle":"Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Subjects With Prurigo Nodularis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-09-11","primaryCompletion":"2022-11-11","completion":"2023-02-21","firstPosted":"2020-08-06","resultsPosted":"2024-07-10","lastUpdate":"2024-07-10"},"enrollment":286,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Prurigo Nodularis"],"interventions":[{"type":"DRUG","name":"Nemolizumab 30 mg","otherNames":["CD14152"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Nemolizumab","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective was to assess the efficacy of nemolizumab (CD14152) compared to placebo in participants greater than or equal to (\\>=) 18 years of age with prurigo nodularis (PN) after a 16 week treatment period.","primaryOutcome":{"measure":"Number of Participants With an Improvement of Greater Than or Equal to (>=) 4 From Baseline in Weekly Average Peak Pruritus Numeric Rating Scale (PP NRS) at Week 16","timeFrame":"Baseline, Week 16","effectByArm":[{"arm":"Nemolizumab","deltaMin":111,"sd":null},{"arm":"Placebo","deltaMin":16,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":8},"locations":{"siteCount":100,"countries":["United States","Austria","Canada","Denmark","Germany","Hungary","Italy","Poland","Sweden","United Kingdom"]},"refs":{"pmids":["37888917","40266487","39602139"],"seeAlso":["http://www.nejm.org/doi/full/10.1056/NEJMoa2301333"]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":187},"commonTop":["Neurodermatitis","COVID-19","Nasopharyngitis","Headache","Cough"]}}